CD39/adenosine pathway is involved in AIDS progression M Nikolova, M Carriere, MA Jenabian, S Limou, M Younas, A Kök, S Huë, ... PLoS pathogens 7 (7), e1002110, 2011 | 204 | 2011 |
Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection MA Jenabian, M El-Far, K Vyboh, I Kema, CT Costiniuk, R Thomas, ... The Journal of infectious diseases 212 (3), 355-366, 2015 | 134 | 2015 |
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy VS Wacleche, JP Goulet, A Gosselin, P Monteiro, H Soudeyns, ... Retrovirology 13, 1-25, 2016 | 123 | 2016 |
Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers MA Jenabian, M Patel, I Kema, C Kanagaratham, D Radzioch, P Thebault, ... PloS one 8 (10), e78146, 2013 | 111 | 2013 |
Elevated abundance, size, and MicroRNA content of plasma extracellular vesicles in viremic HIV-1+ patients: Correlations with known markers of disease progression A Hubert, C Subra, MA Jenabian, PFT Labrecque, C Tremblay, B Laffont, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (3), 219-227, 2015 | 98 | 2015 |
Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection MA Jenabian, N Seddiki, A Yatim, M Carriere, A Hulin, M Younas, ... PLoS pathogens 9 (4), e1003319, 2013 | 94 | 2013 |
Circulating (1→ 3)-β-D-glucan is associated with immune activation during human immunodeficiency virus infection V Mehraj, R Ramendra, S Isnard, FP Dupuy, R Ponte, J Chen, I Kema, ... Clinical Infectious Diseases 70 (2), 232-241, 2020 | 87 | 2020 |
Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease RS Mboumba Bouassa, T Prazuck, T Lethu, MA Jenabian, JF Meye, ... Expert review of anti-infective therapy 15 (6), 613-627, 2017 | 82 | 2017 |
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV‐infected patients receiving antiretroviral therapy JP Routy, JB Angel, M Patel, C Kanagaratham, D Radzioch, I Kema, ... HIV medicine 16 (1), 48-56, 2015 | 82 | 2015 |
Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection MA Jenabian, M Patel, I Kema, K Vyboh, C Kanagaratham, D Radzioch, ... Clinical & Experimental Immunology 178 (1), 102-111, 2014 | 81 | 2014 |
HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets K Vyboh, MA Jenabian, V Mehraj, JP Routy Journal of immunology research 2015 (1), 614127, 2015 | 80 | 2015 |
The lungs as anatomical reservoirs of HIV infection CT Costiniuk, MA Jenabian Reviews in medical virology 24 (1), 35-54, 2014 | 76 | 2014 |
Clinical relevance of kynurenine pathway in HIV/AIDS: an immune checkpoint at the crossroads of metabolism and inflammation. JP Routy, V Mehraj, K Vyboh, W Cao, I Kema, MA Jenabian AIDS reviews 17 (2), 2015 | 74 | 2015 |
Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults MA Jenabian, CT Costiniuk, V Mehraj, FM Ghazawi, R Fromentin, ... Aids 30 (18), 2777-2786, 2016 | 72 | 2016 |
Identification of novel HIV-1 dependency factors in primary CCR4+CCR6+Th17 cells via a genome-wide transcriptional approach A Cleret-Buhot, Y Zhang, D Planas, JP Goulet, P Monteiro, A Gosselin, ... Retrovirology 12, 1-23, 2015 | 67 | 2015 |
HIV persistence in mucosal CD4+ T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy CT Costiniuk, S Salahuddin, O Farnos, R Olivenstein, A Pagliuzza, ... Aids 32 (16), 2279-2289, 2018 | 65 | 2018 |
Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site Y Huang, MT Hoque, MA Jenabian, K Vyboh, SK Whyte, NL Sheehan, ... Journal of Antimicrobial Chemotherapy 71 (7), 1954-1965, 2016 | 61 | 2016 |
Plasma levels of C-type lectin REG3α and gut damage in people with human immunodeficiency virus S Isnard, R Ramendra, FP Dupuy, J Lin, B Fombuena, N Kokinov, I Kema, ... The Journal of infectious diseases 221 (1), 110-121, 2020 | 56 | 2020 |
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment? CT Costiniuk, MA Jenabian Cytokine & growth factor reviews 53, 63, 2020 | 54 | 2020 |
Cannabinoids and inflammation: implications for people living with HIV CT Costiniuk, MA Jenabian Aids 33 (15), 2273-2288, 2019 | 54 | 2019 |